Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
858 results
858
Total Filings
$6907.5B
Total Raised
65
424B4 Offerings
248
ATM Programs
106
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | VLDXW | — | — | — | Public Offering |
$17.36
floor
|
— | — | 3.6M | $62M | — | Velo3D is selling 3,571,428 shares of common stock at $14.00 per share to raise approximately $50 million in gross proceeds for general corporate purposes. |
| Apr 27 | ORKA | Healthcare | Biotechnology | $3.2B | Public Offering | — | $86.23 | — | — | — | Cowen, Goldman Sachs, Stifel | Oruka Therapeutics is raising $500 million through an offering of common stock and pre-funded warrants (exercisable at $0.001), with proceeds for general corporate purposes. |
| Apr 27 | SNOA | Healthcare | Drug Manufacturers - Specialty & Generic | $2M | Public Offering |
$1.35
floor
|
$1.29 | -4.1% | 3.1M | $4M | — | Sonoma Pharmaceuticals is selling 2,962,962 units at $1.35 per unit for approximately $4 million gross proceeds in a firm commitment underwritten offering; proceeds for general corporate purposes. |
| Apr 27 | AUUD | Technology | Software - Application | $392,326 | Public Offering |
$2.36
floor
|
$1.28 | -45.8% | 1.4M | $3M | — | Auddia Inc. is offering 1.4 million common shares and 3.7 million pre-funded warrants at $2.36 combined with common warrants, raising approximately $13.2 million for general corporate purposes and the pending Thramann merger. |
| Apr 24 | LANDO | Real Estate | REIT - Industrial | $743M | ATM | — | $20.53 | — | — | — | — | LANDO selling up to $500 million common stock at-the-market through Virtu Americas and Lucid Capital Markets; proceeds unspecified, agents earn 3.0% commission. |
| Apr 24 | ALT | Healthcare | Biotechnology | $267M | Public Offering |
$3.00
floor
|
$3.02 | +0.7% | 64.2M | $193M | Barclays | Altimmune (ALT) is offering 64.25 million common shares at $3.47 with warrants to purchase 75 million shares; proceeds fund pemvidutide MASH Phase 3 trial development and general corporate purposes. |
| Apr 24 | CTXR | Healthcare | Biotechnology | $7M | Public Offering |
$0.98
floor
|
$0.59 | -40.2% | 4.7M | $5M | — | Citius Pharmaceuticals sells 4.73 million common shares at $0.985 and 345,686 pre-funded warrants at $0.9849 to institutional investors; proceeds fund operations. |
| Apr 24 | QTTB | Healthcare | Biotechnology | $175M | ATM |
$6.48
floor
|
$13.67 | +111.0% | — | — | Cantor Fitzgerald | QTTB is offering up to $75,000,000 of common stock at-the-market through Cantor Fitzgerald; proceeds will be used for general corporate purposes. |
| Apr 23 | NKTR | Healthcare | Biotechnology | $1.5B | Public Offering | — | $77.06 | — | 3.5M | — | Jefferies, Cowen, Piper Sandler, Citigroup | Nektar Therapeutics is offering 3,532,609 shares at $92.00 per share to raise approximately $325 million, with net proceeds of $305.5 million before expenses. |
| Apr 23 | TDIC | Communication Services | Entertainment | $971,530 | Public Offering |
$0.75
floor
|
$3.97 | +429.3% | — | — | — | Dreamland Limited is offering up to 6 million Class A Ordinary Shares at $0.75 per share and 30 million warrants at $0.05 exercise price in a best-efforts offering to raise capital. |
| Apr 23 | DVLT | Technology | Information Technology Services | $103M | Public Offering |
$6.12
floor
|
$0.36 | -94.0% | 75.9M | $465M | — | Divalto (DVLT) is issuing 75,942,666 common shares to Vivasor, Inc. as consideration for purchasing 8,163,265 Vivasor Series A shares for $50 million; no proceeds to DVLT. |
| Apr 23 | TOYWF | — | — | — | ATM |
$13.78
floor
|
— | — | — | — | — | Toyo Co., Ltd selling up to $30 million ordinary shares at-the-market through Roth Capital Partners and H.C. Wainwright at $13.78/share; proceeds for general corporate purposes. |
| Apr 23 | LUCD | Healthcare | Medical - Devices | $107M | Public Offering |
$1.31
floor
|
$1.04 | -20.2% | 18.0M | $24M | — | Lucid Diagnostics Inc. is selling 18,000,000 common shares at $1.00 per share, raising $18,000,000, with proceeds after underwriting discounts of approximately $16,920,000 for general corporate purposes. |
| Apr 23 | MYSEW | — | — | — | ATM |
$3.81
floor
|
— | — | 750K | $3M | — | Myseum.AI, Inc. is offering up to $2,754,500 in common stock through a sales agreement with The Benchmark Company, LLC; proceeds will supplement previous $3.3 million raised under the same agreement. |
| Apr 23 | LVO | Communication Services | Entertainment | $58M | Public Offering |
$4.81
floor
|
$5.28 | +9.8% | 1.0M | $5M | — | LiveOne issues 1,000,000 common shares at $7.50 each to BMI Inc., raising $7.5 million to settle music royalty obligations through March 31, 2027. |
| Apr 23 | LZM-WT | — | — | — | Public Offering |
$4.91
floor
|
— | — | — | — | — | Lifezone Metals Limited is selling 5,700,000 ordinary shares at $4.40/share to institutional investors, raising approximately $25.1 million, with proceeds for general corporate purposes. |
| Apr 23 | LZM-WT | — | — | — | Public Offering |
$4.40
floor
|
— | — | — | — | — | Lifezone Metals Limited is offering 5,700,000 ordinary shares at $4.40 per share to raise $25.08 million gross proceeds ($23.58 million net), with Roth Capital Partners as placement agent. |
| Apr 23 | OTLK | Healthcare | Biotechnology | $59M | Public Offering |
$0.31
floor
|
$1.43 | +359.7% | 16.1M | $5M | — | Outlook Therapeutics offering 16,129,033 shares at $0.31/share to raise approximately $5.0 million, with concurrent warrants; proceeds for general corporate purposes. |
| Apr 22 | MAZE | Healthcare | Biotechnology | $1.8B | Public Offering | — | $33.25 | — | 850K | — | — | Maze Therapeutics selling 5.54 million shares and 850,000 pre-funded warrants at $23.50 per share, raising $150.2 million gross proceeds for general corporate purposes. |
| Apr 22 | SKYQ | Energy | Oil & Gas Integrated | $8M | ATM |
$12.59
floor
|
$2.63 | -79.1% | — | — | Cantor Fitzgerald | Sky Quarry Inc. is raising up to $12.6 million by selling common stock through Muriel Siebert & Co., LLC under an amended sales agreement, with proceeds for general corporate purposes. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →